TG Therapeutics Payables and Accrued Expenses (Quarterly) Insights

TG Therapeutics, Inc. (TGTX)

31.20 -0.44 (-1.39%) USD | NASDAQ | Jan 23, 16:00

31.27 +0.07 (+0.22%) After-Hours: 18:48

View Payables and Accrued Expenses (Quarterly) for TGTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	Upgrade
MannKind Corp.	Upgrade
Karyopharm Therapeutics, Inc.	Upgrade
Axsome Therapeutics, Inc.	Upgrade
Krystal Biotech, Inc.	Upgrade